Literature DB >> 26324275

Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.

Aurélie Renvoisé1, Florence Brossier1, Eve Galati2, Nicolas Veziris1, Wladimir Sougakoff1, Alexandra Aubry1, Jérôme Robert1, Emmanuelle Cambau3, Vincent Jarlier1, Christine Bernard4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26324275      PMCID： PMC4604394          DOI： 10.1128/AAC.01027-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex.

Authors:  M A Jamal; S Maeda; N Nakata; M Kai; K Fukuchi; Y Kashiwabara
Journal:  Tuber Lung Dis       Date:  2000

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.

Authors:  Aurélie Renvoisé; Christine Bernard; Nicolas Veziris; Eve Galati; Vincent Jarlier; Jérôme Robert
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

4.  Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Authors:  Sylvaine Bastian; Nicolas Veziris; Anne-Laure Roux; Florence Brossier; Jean-Louis Gaillard; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

Review 5.  Natural and acquired macrolide resistance in mycobacteria.

Authors:  F Doucet-Populaire; K Buriánková; J Weiser; J-L Pernodet
Journal:  Curr Drug Targets Infect Disord       Date:  2002-12

6.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

7.  Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.

Authors:  F Doucet-Populaire; C Truffot-Pernot; J Grosset; V Jarlier
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

8.  The role of efflux pumps in macrolide resistance in Mycobacterium avium complex.

Authors:  Liliana Rodrigues; Daniela Sampaio; Isabel Couto; Diana Machado; Winfried V Kern; Leonard Amaral; Miguel Viveiros
Journal:  Int J Antimicrob Agents       Date:  2009-09-08       Impact factor: 5.283

9.  In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.

Authors:  Barbara A Brown-Elliott; Elena Iakhiaeva; David E Griffith; Gail L Woods; Jason E Stout; Cameron R Wolfe; Christine Y Turenne; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2013-08-14       Impact factor: 5.948
  9 in total
  3 in total

1.  Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.

Authors:  Simone Mok; Margaret M Hannan; Lars Nölke; Patrick Stapleton; Niamh O'Sullivan; Philip Murphy; Anne Marie McLaughlin; Eleanor McNamara; Margaret M Fitzgibbon; Thomas R Rogers
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Authors:  Hee Jae Huh; Su-Young Kim; Hyang Jin Shim; Dae Hun Kim; In Young Yoo; On-Kyun Kang; Chang-Seok Ki; So Youn Shin; Byung Woo Jhun; Sung Jae Shin; Charles L Daley; Won-Jung Koh; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

3.  Insights on the relationship between structure vs. toxicological activity of antibacterial rhodamine-labelled 3-hydroxy-4-pyridinone iron(III) chelators in HepG2 cells.

Authors:  Tânia Moniz; Diana Dias da Silva; Helena Carmo; Baltazar de Castro; Maria de Lourdes Bastos; Maria Rangel
Journal:  Interdiscip Toxicol       Date:  2019-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.